Holen Sie sich die Stockscreener-App
2.06
4.83%
0.095
Handel nachbörslich:
2.06
Fractyl Health Inc Aktie (GUTS) Neueste Nachrichten
Lee Ainslie's Strategic Reduction in Fractyl Health Inc Holdings - GuruFocus.com
Fractyl Health Third Quarter 2024 Earnings: US$0.48 loss per share (vs US$9.61 loss in 3Q 2023) - Yahoo Finance
Fractyl Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Fractyl Health president sells $158,540 in stock By Investing.com - Investing.com Canada
Fractyl Health president sells $158,540 in stock - Investing.com
Fractyl Health CEO sells shares worth $238,358 By Investing.com - Investing.com UK
Why This Penny Stock Lost 13% Last Week While Markets Soared - MSN
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
TSX Real Estate Capped Index (TTRE) QuotePress Release - The Globe and Mail
TSX Composite Dividend Index (TXDC) QuotePress Release - The Globe and Mail
S&P 500 Materials [Sector] (SRMA) QuotePress Release - The Globe and Mail
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
TSX Renewable and Clean Tech Index (TXCT) QuotePress Release - The Globe and Mail
Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates - The Manila Times
Fractyl Health Q3: Obesity Treatment Progress Despite Widening Losses; $84.7M Cash Runway | GUTS Stock News - StockTitan
Fractyl Health (GUTS) Scheduled to Post Earnings on Tuesday - Defense World
Fractyl Health (GUTS) Set to Announce Earnings on Tuesday - MarketBeat
Fractyl Health nominates GIP/GLP-1 dual agonist as pancreatic gene therapy candidate for obesity - BioWorld Online
Fractyl Health to Present New Preclinical Data on Sustained - GlobeNewswire
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024 - ForexTV.com
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar - The Bakersfield Californian
Fractyl Health Presented New Analysis from Pooled Data of - GlobeNewswire
Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024 - StockTitan
SG Americas Securities LLC Invests $33,000 in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024 - GlobeNewswire
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024 - GlobeNewswire Inc.
Fractyl Health to Present Compelling Weight Maintenance - GlobeNewswire
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva - The Bakersfield Californian
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024 - StockTitan
14,200 Shares in Fractyl Health, Inc. (NASDAQ:GUTS) Bought by Renaissance Technologies LLC - Defense World
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Significant Increase in Short Interest - MarketBeat
Fractyl Health To Debut On Nasdaq Today - RTTNews
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference - GlobeNewswire
Financial Fitness Check: Examining Fractyl Health Inc. (GUTS)’s Key Ratios - The Dwinnex
Fractyl Health Inc. (GUTS)’s stock price in review: A technical analysis - US Post News
Massachusetts Financial Services Co. MA Acquires 25,829 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health president sells over $188k in company stock By Investing.com - Investing.com Canada
Fractyl Health president sells over $188k in company stock - Investing.com India
Jay David Caplan Sells 65,000 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) Stock - MarketBeat
IPO class of 2024 shows value recovery despite mixed stock performance - BioWorld Online
Fractyl Health stock down 8% following $110M IPO - MSN
Fractyl Health to Participate in Upcoming September Investor Conferences - StockTitan
Fractyl Health, Inc. (NASDAQ:GUTS) Short Interest Down 13.2% in August - MarketBeat
Fractyl Health Inc. (GUTS) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Fractyl Health Inc. (GUTS) can make a big difference with a little luck - SETE News
Fractyl Health Inc. (GUTS) presents a great opportunity, but the stock is slightly undervalued - US Post News
Stock Performance Spotlight: Fractyl Health Inc. (GUTS) Ends the Day at 3.58, Up by 6.23 - The Dwinnex
Investing in Fractyl Health Inc. (GUTS) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Fractyl Health Inc. (GUTS) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Expands By 5.7% - MarketBeat
Fractyl Health Second Quarter 2024 Earnings: US$0.36 loss per share (vs US$14.56 loss in 2Q 2023) - Yahoo Finance
GUTS Stock Earnings: Fractyl Health Beats EPS for Q2 2024 - MSN
GUTSFractyl Health, Inc. Latest Stock News & Market Updates - StockTitan
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates - wallstreet:online
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):